Skip to content
10-Q

Quarterly Report

Medline Inc. MDLN

0002046386-26-000026

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2026 · Mar 28, 2026 824.84M sh
Stock Repurchased Q1 2026 · Mar 28, 2026 $0
Stock Repurchased Q1 2026 · Mar 29, 2025 $9M
Capex Q1 2026 · Mar 28, 2026 $96M
Capex Q1 2026 · Mar 29, 2025 $98M
Operating Cash Flow Q1 2026 · Mar 28, 2026 $412M
Operating Cash Flow Q1 2026 · Mar 29, 2025 $682M
Long Term Debt Q1 2026 · Mar 28, 2026 $12.5B
Long Term Debt Q1 2026 · Dec 31, 2025 $12.48B
Short Term Debt Q1 2026 · Mar 28, 2026 $1M
Short Term Debt Q1 2026 · Dec 31, 2025 $1M
Cash And Equivalents Q1 2026 · Mar 28, 2026 $2.24B
Cash And Equivalents Q1 2026 · Dec 31, 2025 $1.94B
Stockholders Equity Q1 2026 · Mar 28, 2026 $11.27B
Stockholders Equity Q1 2026 · Dec 31, 2025 $10.74B
Current Liabilities Q1 2026 · Mar 28, 2026 $2.54B
Current Liabilities Q1 2026 · Dec 31, 2025 $2.49B
Total Liabilities Q1 2026 · Mar 28, 2026 $19.67B
Total Liabilities Q1 2026 · Dec 31, 2025 $19.2B
Current Assets Q1 2026 · Mar 28, 2026 $11.18B
Current Assets Q1 2026 · Dec 31, 2025 $10.68B
Total Assets Q1 2026 · Mar 28, 2026 $39.01B
Total Assets Q1 2026 · Dec 31, 2025 $38.48B
Eps Diluted Q1 2026 · Mar 28, 2026 $0.16
Eps Basic Q1 2026 · Mar 28, 2026 $0.16
Sga Expense Q1 2026 · Mar 28, 2026 $1.23B
Sga Expense Q1 2026 · Mar 29, 2025 $1.07B
Operating Income Q1 2026 · Mar 28, 2026 $422M
Operating Income Q1 2026 · Mar 29, 2025 $571M
Gross Profit Q1 2026 · Mar 28, 2026 $1.84B
Gross Profit Q1 2026 · Mar 29, 2025 $1.82B
Cost Of Revenue Q1 2026 · Mar 28, 2026 $5.51B
Cost Of Revenue Q1 2026 · Mar 29, 2025 $4.82B
Revenue Q1 2026 · Mar 28, 2026 $7.35B
Revenue Q1 2026 · Mar 29, 2025 $6.64B
Net Income Q1 2026 · Mar 29, 2025 $319M